FDA
- Status: approved
🇺🇸 Use of insulin glargine twice daily in United States
Use of insulin glargine twice daily (Use of insulin glargine twice daily) regulatory status in United States.
Marketing authorisation
Use of insulin glargine twice daily in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Use of insulin glargine twice daily approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Use of insulin glargine twice daily in United States?
Eastern Virginia Medical School is the originator. The local marketing authorisation holder may differ — check the official source linked above.